Suchergebnisse - "Bouscary, Didier"

PubPharm (7)

1

AMPK-PERK axis represses oxidative metabolism and enhances apoptotic priming of mitochondria in acute myeloid leukemia

enthalten in: Cell reports | 2022

von Grenier, A. | Poulain, L. | Mondesir, J. | +19

2

Asciminib and ponatinib combination in Philadelphia chromosome-positive acute lymphoblastic leukemia

enthalten in: Leukemia & lymphoma | 2021

von Zerbit, J. | Tamburini, J. | Goldwirt, L. | +7

3

Ponatinib-based therapy in adults with relapsed or refractory Philadelphia chromosome-positive acute lymphoblastic leukemia : results of the real-life OPAL study

enthalten in: Leukemia & lymphoma | 2020

von Tavitian, S. | Uzunov, M. | Bérard, E. | +13

4

Co-activation of AMPK and mTORC1 : a therapeutic application of synthetic lethality in acute myeloid leukemia

enthalten in: Medecine sciences : M/S | 2015

von Tamburini, J. | Poulain, L. | Bouscary, D. | +1

5

Co-activation of AMPK and mTORC1 Induces Cytotoxicity in Acute Myeloid Leukemia

enthalten in: Cell reports | 2015

von Sujobert, P. | Poulain, L. | Paubelle, E. | +23

6

The FLT3 and Pim kinases inhibitor SGI-1776 preferentially target FLT3-ITD AML cells

enthalten in: Blood | 2012

von Hospital, M. | Green, A. | Lacombe, C. | +3

7

Dual inhibition of PI3K and mTORC1/2 signaling by NVP-BEZ235 as a new therapeutic strategy for acute myeloid leukemia

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2010

von Chapuis, N. | Tamburini, J. | Green, A. | +14

1
[1]